MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Appropriate Use Criteria Update
Assessing the appropriate use of PCI in your practice.
By Steven P. Marso, MD
IVUS With Virtual Histology in Clinical Practice
A novel imaging technology for assessing vulnerable plaque.
By Adnan Khalid, MD, and Steven P. Marso, MD
Terumo Launches Glidesheath Slender Sheath for Transradial PCI
July 30, 2013—Terumo Interventional Systems (Somerset, NJ) announced the launch of the Glidesheath Slender device, a hydrophilic-coated introducer sheath specifically designed to deliver larger devices through a smaller radial access.
Concepts in PCI
By Ted E. Feldman, MD, FESC, FACC, FSCAI
CHIEF MEDICAL EDITOR'S PAGE: We Are Only as Good as What We See
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor
Radial Versus Femoral: Choosing the Best Option for Each Patient
Experts Sunil Rao, MD, and Timothy Sanborn, MD, discuss their opinions on access, pharmacology, patient selection, and the use of closure devices.
The Impact of Diabetes on PCI Case Selection
An evaluation of the current therapeutic options for patients with diabetes mellitus and cardiovascular disease.
By Victor Alfonso Jiménez Díaz, MD, and Andrés Iñiguez Romo, MD
Highlights from EuroPCR
DES, COURAGE, and the Great Debate
Are Contemporary Femoral Approaches Comparable to Radial?
Experience and data on femoral access best practices and how they stack up against the radial approach.
By Matthew I. Tomey, MD, And Roxana Mehran, MD
The CoreValve Program
Cardiac Interventions Today interviews Carlos E. Ruiz, MD, PhD, who shares his expertise on the current status of the CoreValve device and trial data.
Use of IVUS for Coronary CTO Procedures
An update on the technology and use of IVUS in this challenging coronary niche.
By John E. Coletta, MD; Etsuo Tsuchikane, MD, PhD; Ravi Nair, MD; Daniel I. Simon, MD; and Marco A. Costa, MD, PhD
Challenging Cases: What Would You Do?
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Shakeel A. Qureshi, MD, FRCP, FRCPCH
Italian Study Evaluates Changes in Hospital Admissions for STEMI Caused by COVID-19 Pandemic
August 14, 2020—Preliminary results from a cardiovascular regional public service health care hub in Italy demonstrated a significantly longer time from symptoms onset to hospital admission among patients with ST-segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic compared with the same time period in the previous 2 years.